Cytokinetics, Incorporated
CYTK NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 6, 2026
ET
EPS Est.
-1.63
EPS Actual
-1.50
Revenue Est.
$17.6M
Revenue Actual
$28.6M
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-1.45
Revenue Est.
$39.8M
Company Overview
Cytokinetics, Incorporated (ticker CYTK) is listed on NASDAQ with a market cap of about $9.56B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), After-market, with consensus EPS of -1.45. In the last 15 reported quarters, EPS beat consensus estimates 4 times.
Actual EPS TrendRecently15Term · Mar 1, 2023 → Aug 6, 2026
Mar 1, 2023Range: -2.55 ~ -1.12Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -1.63 | -1.50 | $17.6M | $28.6M |
| May 5, 2026 | -- | -1.67 | -1.67 | $8.5M | $19.4M |
| Feb 24, 2026 | -- | -1.48 | -1.50 | $6.9M | $17.8M |
| Nov 5, 2025 | -- | -1.59 | Below forecast↓-2.55 | $6M | $1.9M |
| Aug 7, 2025 | -- | -1.34 | Above forecast↑-1.12 | $2.1M | $66.8M |
| May 6, 2025 | -- | -1.41 | -1.36 | $2.8M | $1.6M |
| Feb 27, 2025 | -- | -1.29 | -1.26 | $14.3M | $16.9M |
| Nov 6, 2024 | -- | -1.27 | -1.36 | $2.1M | $463000 |
| Aug 8, 2024 | -- | -1.02 | Below forecast↓-1.31 | $920000 | $249000 |
| May 8, 2024 | -- | -1.16 | -1.33 | $900000 | $835000 |
| Feb 27, 2024 | -- | -1.03 | Below forecast↓-1.38 | $10.8M | $1.7M |
| Nov 2, 2023 | -- | -0.72 | Below forecast↓-1.35 | $11.1M | $378000 |
| Aug 3, 2023 | -- | -1.23 | -1.34 | $5.8M | $867000 |
| May 4, 2023 | -- | -1.24 | -1.38 | $2.1M | $4.6M |
| Mar 1, 2023 | -- | -1.22 | Below forecast↓-1.45 | $7.1M | $2M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-06 ↗
Earnings Release8-K · 2026-08-06 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-02-26 ↗
Earnings Release8-K · 2026-02-24 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
